ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,567.19
      1.06%
      US Tech 100
      19,828.00
      0.95%
      Dow Jones
      39,375.87
      0.17%
      Brent Oil
      86.775
      0.00%
      Bitcoin
      56,864.82
      0.38%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Esperion Therapeutics Inc (ESPR)

      7. Esperion Therapeutics Inc (ESPR) News

      ESPR

      Esperion Therapeutics (ESPR)

      Esperion Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ESPR
      DateTimeSourceHeadlineSymbolCompany
      10/19/20224:00PMGlobeNewswire Inc.Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:ESPREsperion Therapeutics Inc
      10/17/20228:02AMGlobeNewswire Inc.Esperion to Report Third Quarter 2022 Financial Results November 1, 2022NASDAQ:ESPREsperion Therapeutics Inc
      09/20/20224:41PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ESPREsperion Therapeutics Inc
      08/30/20228:00AMGlobeNewswire Inc.Esperion to Participate in Upcoming September Investor ConferencesNASDAQ:ESPREsperion Therapeutics Inc
      08/26/202210:35AMTipRanksH.C. Wainwright Sticks to Their Buy Rating for Esperion (ESPR)NASDAQ:ESPREsperion Therapeutics Inc
      08/26/20228:16AMGlobeNewswire Inc.Esperion Announces Bempedoic Acid (NEXLETOL®) Recommended as Oral Non-Statin Therapy for LDL-Cholesterol Lowering in American College of Cardiology Expert Consensus Decision PathwayNASDAQ:ESPREsperion Therapeutics Inc
      08/23/20225:00PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ESPREsperion Therapeutics Inc
      08/18/20224:11PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      08/18/20224:05PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ESPREsperion Therapeutics Inc
      08/04/20224:05PMGlobeNewswire Inc.Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:ESPREsperion Therapeutics Inc
      08/02/20224:25PMTipRanksEsperion (ESPR) Gets a Buy Rating from NeedhamNASDAQ:ESPREsperion Therapeutics Inc
      08/02/202212:35PMTipRanksJMP Securities Keeps a Buy Rating on Esperion (ESPR)NASDAQ:ESPREsperion Therapeutics Inc
      08/02/202210:56AMTipRanksH.C. Wainwright Sticks to Its Buy Rating for Esperion (ESPR)NASDAQ:ESPREsperion Therapeutics Inc
      08/02/20227:25AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ESPREsperion Therapeutics Inc
      08/02/20227:00AMGlobeNewswire Inc.Esperion Reports Second Quarter 2022 Financial Results and Provides Company UpdateNASDAQ:ESPREsperion Therapeutics Inc
      07/25/20223:00PMGlobeNewswire Inc.Esperion Announces Establishment of Scientific Advisory Board to Support Pipeline and Life Cycle ManagementNASDAQ:ESPREsperion Therapeutics Inc
      07/20/20224:28PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      07/20/20224:28PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      07/15/202212:44PMTipRanksEsperion (ESPR) Receives a Sell from Morgan StanleyNASDAQ:ESPREsperion Therapeutics Inc
      07/12/20228:00AMGlobeNewswire Inc.Esperion to Report Second Quarter 2022 Financial Results August 2, 2022NASDAQ:ESPREsperion Therapeutics Inc
      06/21/20224:08PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      06/21/20224:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      06/09/20224:49PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      06/09/20224:47PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      06/09/20224:46PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      06/03/202212:30PMGlobeNewswire Inc.Real World Data Analysis Reveals Nearly Half of All Adults at High Risk for ASCVD and Eligible for a Statin Were Not On Any StatinNASDAQ:ESPREsperion Therapeutics Inc
      06/02/20228:00AMGlobeNewswire Inc.Esperion to Participate in the 2022 Jefferies Global Healthcare ConferenceNASDAQ:ESPREsperion Therapeutics Inc
      06/01/20224:25PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      06/01/20224:11PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ESPREsperion Therapeutics Inc
      06/01/20224:00PMGlobeNewswire Inc.Esperion Announces the Appointment of J. Martin Carroll to its Board of DirectorsNASDAQ:ESPREsperion Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:ESPR